We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Meeting report: myelodysplastic syndromes at ASH 2007.
- Authors
Itzykson, R.; Gardin, C.; Fenaux, P.
- Abstract
Myelodysplastic syndromes (MDS) remain challenging to both clinicians and biologists. This year's edition of the Annual Meeting of the American Society of Hematology has provided several breakthroughs in the biology and therapeutics of MDS, such as uncovering of the molecular genetics of the 5q− syndrome and clear evidence of a survival advantage with a hypomethylating agent in high-risk MDS. We summarize those advances and delineate some perspectives for these diseases.Leukemia (2008) 22, 893–897; doi:10.1038/leu.2008.45; published online 6 March 2008
- Subjects
MEETINGS; MYELODYSPLASTIC syndromes; BONE marrow diseases; MOLECULAR genetics; MOLECULAR biology
- Publication
Leukemia (08876924), 2008, Vol 22, Issue 5, p893
- ISSN
0887-6924
- Publication type
Article
- DOI
10.1038/leu.2008.45